AI assistant
Sending…
IMMUNIC, INC. — Director's Dealing 2018
Sep 17, 2018
10196_dirs_2018-09-17_d8a7fb11-d8d7-4065-8fb1-2208205e985a.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: VITAL THERAPIES INC (VTL)
CIK: 0001280776
Period of Report: 2018-09-13
Reporting Person: BIENAIME JEAN JACQUES (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2018-09-13 | Common Stock | S | 20000 | $0.47 | Disposed | 45119 | Direct |
More from IMMUNIC, INC.
Regulatory Filings
2026
May 28
Board/Management Information
2026
May 27
Board/Management Information
2026
May 19
Regulatory Filings
2026
May 13
Interim / Quarterly Report
2026
May 13
Earnings Release
2026
May 13
Regulatory Filings
2026
Apr 30
Regulatory Filings
2026
Apr 28
Board/Management Information
2026
Apr 28
Regulatory Filings
2026
Apr 23